Applied DNA Schedules Third Quarter Fiscal 2021 Financial Results Conference Call and Webcast on Thursday, August 12, 2021


STONY BROOK, NY – (COMMERCIAL THREAD) – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in the manufacture of DNA based on polymerase chain reaction (PCR) and technologies based on nucleic acids, today announced that it will release financial results for the third quarter of fiscal 2021 after market close on Thursday, August 12, 2021. Company management will discuss the results on a conference call and a simultaneous webcast at 4:30 p.m. EDT the same day. The presentation slides will also be posted on the “IR Calendar and Corporate Presentations” subpage of the Company’s website and integrated into the live webcast.

Conference Call and Webcast Information – Live

Conference Call and Webcast Information – Replay

A replay of the conference call will be available for one week starting one hour after the end of the live conference call.

The webcast and accompanying PowerPoint presentation will also be archived on the “IR Calendar and Corporate Presentations” page listed under the Investor Relations drop-down menu on the Company’s website.

About Applied DNA Sciences

Applied DNA markets LinearDNA ™, its proprietary large-scale polymerase chain reaction (“PCR”) -based manufacturing platform that enables large-scale production of specific DNA sequences.

LinearDNA platform has utility in the field of nucleic acids in vitro diagnostics and market for the development and manufacture of drugs based on preclinical nucleic acids. The platform is used to make DNA for customers as components of in vitro diagnostic tests and for the preclinical development of nucleic acid-based drugs in the fields of adoptive cell therapies (CAR T and TCR therapies), DNA vaccines (antiviral and anticancer), RNA therapies, based therapies evenly spaced short palindromic repeats (CRISPR); and gene therapy. Applied DNA is also the manufacturer of the EUA-authorized Linea ™ COVID-19 test kit.

The LinearDNA platform also has non-organic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Major end markets include government / millet, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.

Visit for more information. follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common shares are listed on the NASDAQ under the symbol “APDN” and its publicly traded warrants are listed on OTC under the symbol “APPDW”.

Applied DNA is a member of the Russell Microcap® Index.

Source link


About Author

Leave A Reply